Intensive glycemic control in Type 2 diabetes mellitus has both benefits and risks: a review of the VADT study
2010-07-22T20:14:23Z
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Intensive glycemic control in Type 2 diabetes mellitus has both benefits and risks: a review of the VADT study
Authors
Published Date
2010-07-22T20:14:23Z
Publisher
Type
Other
Abstract
Intensive glycemic control (A1c ~ 7%) in patients with Type 2 diabetes mellitus has no significant effect on the rates of major cardiovascular events, death, peripheral neuropathy, and retinopathy compared with standard therapy (A1c ~ 8.5%) when measured within a mean 5.6 year treatment period. Intensive glycemic control does decrease the progression of albuminuria (P= 0.01) in this treatment window, but is associated with higher overall rates of adverse events (P = 0.05), including hypoglycemia (P < 0.001) and dyspnea (P = 0.006).
Description
The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.
Related to
Replaces
License
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.